Clinical Trials Logo

Colon Cancer clinical trials

View clinical trials related to Colon Cancer.

Filter by:

NCT ID: NCT02431676 Completed - Breast Cancer Clinical Trials

Survivorship Promotion In Reducing IGF-1 Trial

SPIRIT
Start date: May 2015
Phase: Phase 2
Study type: Interventional

This is a prospective, single-center randomized trial with three arms, and an allocation ratio of 1:1:1. The study design is an efficacy study to evaluate the effect of metformin and coach-directed behavioral weight loss versus self-directed weight loss on insulin-like growth factor (IGF)-1 and IGF-1 to THE IGFBP-III ratio blood levels after 6 and 12 months of intervention. The coach-directed Behavioral Weight Loss arm is a web-based remote delivery and communication system that promotes healthy behavioral changes. The Metformin arm is a pharmaceutical intervention of oral metformin. This is a secondary prevention study for men and women who have survived solid malignant tumors

NCT ID: NCT02430948 Completed - Breast Cancer Clinical Trials

Improving Compliance With Medical Testing Guidelines

Start date: January 2014
Phase: N/A
Study type: Interventional

The study hypothesis is that clearer visual presentation of guideline recommendations and educational outreach, or academic detailing, can improve guideline compliance. However, it will investigate other aspects of screening-related decision-making, such as provider and patient beliefs about screening, provider-patient communication and patient's willingness to forgo expected testing. The research question is whether educational interventions can decrease non-compliance with screening guidelines for 5 common cancers.

NCT ID: NCT02387307 Completed - Melanoma Clinical Trials

A Study of rSIFN-co in Subjects With Advanced Solid Tumors

rSIFN-01
Start date: July 2013
Phase: Phase 1
Study type: Interventional

This is a multicenter, open-label, phase I study of rSIFN-co (3 times a week via subcutaneous injection for 21 days, with 1 week of washout per cycle).

NCT ID: NCT02377232 Completed - Colon Cancer Clinical Trials

Simultaneous Improvement in Colon Cancer Screening Rates and Patient-Centered Care

CRCSreening
Start date: May 2015
Phase: N/A
Study type: Interventional

Several screening methods exist to screen patients for CRC ranging from invasive (i.e., colonoscopy) to less invasive (i.e., testing the stool for blood). Although choice between screening methods is recommended, patients are not currently offered an unbiased choice and physicians generally recommend only colonoscopy. In this project, the investigators will answer the following questions: 1) Is it feasible to incorporate a DA in the AHP protocol?; 2) Is it feasible to incorporate mailing patients a stool blood test?; 3) Does the DA change CRC screening decision quality, using proxy measures such as knowledge and intent; and 4) Does the DA change the proportion of participants that complete a CRC screening test? To answer these questions the investigators will compare survey responses and CRC test type completed between two AHP CRC surveillance patients groups - those that received usual care versus those that received the DA.

NCT ID: NCT02331641 Completed - Colon Cancer Clinical Trials

Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases.

Start date: January 2005
Phase: N/A
Study type: Observational

The performance of multiple minor hepatectomies (MMH) instead of major hepatectomies (MH) in patients with colorectal liver metastases (CLM) is object of debate. We build a study, using the propensity score matched analysis, to compare the short- and long-term outcome of the tow groups of patients.

NCT ID: NCT02324374 Completed - Colon Cancer Clinical Trials

Endocytoscopy and Colorectal Neoplasia

Start date: June 2011
Phase: N/A
Study type: Interventional

This will be a feasibility study to evaluate the role of endocytoscopy in classifying colorectal polyps in vivo. The primary outcomes will be to determine the key endocytoscopy image features of neoplastic and non-neoplastic colorectal polyps. The target population will include adult subjects undergoing screening and surveillance colonoscopies.

NCT ID: NCT02314871 Completed - Colon Cancer Clinical Trials

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

Start date: January 2015
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the effects of three types of perioperative analgesia on the number of circulating cancer cells (representing minimal residual disease) following radical colon cancer surgery. Patients will be randomized into one of three groups. The intervention group will receive combined regional and general anesthesia during surgery and postoperative epidural analgesia. The two control groups will receive balanced general anesthesia and either morphine-based or piritramide-based postoperative analgesia. We hypothesize that epidural analgesia will be favorable to both piritramide-based and morphine-based analgesia and that piritramide-based analgesia will be favorable to morphine-based analgesia with regard to the number of circulating cancer cells and its development in the early postoperative period.

NCT ID: NCT02305368 Completed - Colon Cancer Clinical Trials

Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4

Oncogramme
Start date: March 2011
Phase: N/A
Study type: Observational [Patient Registry]

In patients with colonic adenocarcinoma stage 4 which are potentially resectable metastases (lung and liver metastases), treatment with chemotherapy is necessary but not end in success in 10% of cases. The development of techniques for administering personalized treatment becomes necessary for these patients. Thus, in vitro tests on cells from tumors of these patients and evaluating the effect of chemotherapy on these could be made for each patient. In France, the company develops Oncomedics these tests. This is a pilot study that will make a first evaluation under actual conditions of chimio-oncogramme.

NCT ID: NCT02288611 Completed - Colon Cancer Clinical Trials

The Impact of Palm Date Intake on Colon Health Biomarkers

AJWA
Start date: May 2012
Phase: N/A
Study type: Interventional

This aim of this study is to investigate the prebiotic potential of date fruits in healthy human volunteers compared to a control diet. Each arm was 21 days in duration, separated by a 14 days washout period. Faecal samples, and blood samples will be collected from each volunteer and high resolution analytical techniques (HPLC, LC-MS and NMR) will be employed to characterise the whole system metabolic response to ingestion of date fruits compared to the control. Changes in microbial parameters and metabolite profiles will be correlated with changes in biomarkers of chronic disease, including faecal water genotoxicity, cellular reactions, blood lipids and bowel movements.

NCT ID: NCT02272036 Completed - Colon Cancer Clinical Trials

Short Message Service in Colonoscopy Preparation (PERICLES-II-SMS)

PERICLES-II
Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze if integration of new media (SMS) could improve the quality of colonoscopy preparation.